Oncotype DX Colon Cancer Test May Reduce Medical Costs Associated with Stage...
REDWOOD CITY, Calif., Sept. 12, 2014 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that...
View ArticleAdvances in Genomic Testing-What you Need to Know
Q: What is genomic testing? A: Genomic testing looks at a group of genes and their varying levels of expression. This gene expression or activity can characterize how genes interact with one another...
View ArticlePreoperative Arterial Chemotherapy Appears Superior to Post-operative...
CancerConnect News: Doctors from China have reported at the annual Gastrointestinal Cancers Symposium sponsored by the American Society of Clinical Oncology in San Francisco that giving preoperative...
View ArticleTreatment Outcomes in Stage III Colon Cancer Appear Better in Aspirin, COX-2...
CancerConnect News: According to the results of a study recently reported in the Journal of the National Cancer Institute, patients with stage III colon cancer who take aspirin or other agents that...
View ArticleMore Effective Surgery for Colon Cancer with Laparoscopic versus Open Colectomy
Less invasive surgery for colon cancer with laparoscopic colectomy improves outcomes. These findings were reported in the Journal of the National Cancer Institute. Historically, surgical treatment for...
View ArticleVectibix® Improves Survival in Colorectal Cancer, Demonstrates Importance of...
The addition of Vectibix® (panitumumab) to best supportive care improves survival over best standard care alone among colorectal cancer patients […] The post Vectibix® Improves Survival in Colorectal...
View ArticleStent Placement Reduces Need for Stoma in Some Colorectal Cancers
The placement of a stent as initial emergency treatment for colon obstruction reduces the need for a stoma without adversely […] The post Stent Placement Reduces Need for Stoma in Some Colorectal...
View ArticleAddition of Eloxatin® Following Surgery Delays Cancer Progression in Certain...
The addition of the chemotherapy combination consisting of Eloxatin (oxalipatin) plus 5-fluorouracil (5 FU) following surgery reduces the risk of […] The post Addition of Eloxatin® Following Surgery...
View ArticleMany Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through...
One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation […] The post Many Early Onset Colon Cancers are Caused by Genetic Mutations...
View ArticleColon Cancer Surgery: Minimally Invasive Laparoscopic Surgery versus Open...
If you’ve been diagnosed with colon cancer and your healthcare team has determined that you’re a candidate for either complete […] The post Colon Cancer Surgery: Minimally Invasive Laparoscopic Surgery...
View Article
